Literature DB >> 8915574

Trk receptor alterations in Alzheimer's disease.

B Connor1, D Young, P Lawlor, W Gai, H Waldvogel, R L Faull, M Dragunow.   

Abstract

The expression of trk receptors in postmortem normal, Huntington's disease and Alzheimer's disease human brains was investigated using immunohistochemistry, in-situ hybridisation and Western blotting. Alzheimer's disease hippocampi displayed an increase in trkA receptor levels in astrocytes in the CA1 region, some of which were associated with beta-amyloid-positive plaques. Truncated trkB receptors were found in high levels in senile plaques, while the full-length receptor was expressed in glial-like cells in the hippocampus of Alzheimer's disease brains. In-situ hybridisation studies indicated that trk receptor mRNA was also elevated in Alzheimer's. The appearance of trkA and trkB receptors in astrocytes and plaques in Alzheimer's disease might be related to beta-amyloid deposition and could be implicated in the development of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915574     DOI: 10.1016/s0169-328x(96)00040-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  23 in total

1.  Stage-dependent BDNF serum concentrations in Alzheimer's disease.

Authors:  C Laske; E Stransky; T Leyhe; G W Eschweiler; A Wittorf; E Richartz; M Bartels; G Buchkremer; K Schott
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

2.  A high cholesterol diet given to apolipoprotein E-knockout mice has a differential effect on the various neurotrophin systems in the hippocampus.

Authors:  Zhi-Yu Wang; Takanori Miki; Yan Ding; Shi-Jie Wang; Yu-Huan Gao; Xiao-Ling Wang; Yu-Hua Wang; Toshifumi Yokoyama; Katsuhiko Warita; Ken-ichi Ohta; Shingo Suzuki; Taira Ohnishi; Takashi Obama; Kuldip S Bedi; Yoshiki Takeuchi; Bao-En Shan
Journal:  Metab Brain Dis       Date:  2011-08-09       Impact factor: 3.584

Review 3.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Olesoxime protects embryonic cortical neurons from camptothecin intoxication by a mechanism distinct from BDNF.

Authors:  Caroline Gouarné; Marc Giraudon-Paoli; Mathieu Seimandi; Clotilde Biscarrat; Gwenaëlle Tardif; Rebecca M Pruss; Thierry Bordet
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology.

Authors:  Patricia F Kao; Meredith G Banigan; Charles R Vanderburg; Ann C McKee; Peter R Polgar; Sudha Seshadri; Ivana Delalle
Journal:  J Neuropathol Exp Neurol       Date:  2012-07       Impact factor: 3.685

6.  Gestational exposure to methylmercury alters neurotrophin- and carbachol-stimulated phosphatidylinositide hydrolysis in cerebral cortex of neonatal rats.

Authors:  W M Mundy; D Parran; S Barone
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

7.  Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease.

Authors:  Patricia F Kao; David A Davis; Meredith G Banigan; Charles R Vanderburg; Sudha Seshadri; Ivana Delalle
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

Review 8.  Brain-derived neurotrophic factor in neurodegenerative diseases.

Authors:  Chiara Zuccato; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

9.  Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.

Authors:  Bernadeta Michalski; Maria M Corrada; Claudia H Kawas; Margaret Fahnestock
Journal:  Neurobiol Aging       Date:  2015-08-29       Impact factor: 4.673

10.  RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer's disease.

Authors:  Albert Giralt; Cristina Malagelada; Leticia Pérez-Sisqués; Anna Sancho-Balsells; Júlia Solana-Balaguer; Genís Campoy-Campos; Marcel Vives-Isern; Ferran Soler-Palazón; Marta Anglada-Huguet; Miguel-Ángel López-Toledano; Eva-Maria Mandelkow; Jordi Alberch
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.